Join representatives from Amador Biologics to discuss opportunities in the rapidly-growing biotech field in Maryland. Speakers will include an HR representative, a research lab director, and an alumna of UMBC’s [….]
Follow in the paw prints of a Retriever and find out what it’s really like to be an undergraduate student at UMBC-Shady Grove! Learn more about our Translational Life Science [….]
Network with fellow biopharma, academic, and government professionals and learn about the rapidly-growing field of cell and gene therapy. Featuring keynote speaker Peter Marks, M.D., Ph.D., Director of the U.S. [….]
UMBC professor hopes his new NIH-funded research can speed up the drug approval process Email Facebook LinkedIn Twitter Share article
Chengpeng Chen hopes that his research at UMBC can create a more accurate model of how human organs work, making it easier for drug companies in Baltimore and beyond to earn FDA approval.
Courtesy of UMBC
By Matt Hooke – Reporter
October 10, 2022, 07:32am EDT
A University of Maryland, Baltimore County professor hopes to rapidly speed up the drug approval process, making it easier for drugs to get to market and help patients.
In August, Chengpeng Chen earned a five-year, $1.7 million grant from the National Institutes of Health (NIH) to create a new way to model how drugs will impact human organs, starting with the liver. The device would shorten the time it takes to get U.S. Food and Drug Administration approval by providing a more accurate view of how drugs impact the human body than current testing methods. Baltimore is a hub for medical research, with several area pharmaceutical companies, such as MIRA1a Therapeutics and Alphyn Biologics earning substantial funding rounds. A faster way to get through the FDA approval process could be a boon to the…
The Maryland Stem Cell Research Commission announced it will grant $4,165,325 in award funding to innovative research that will strengthen and advance stem cell treatments and technologies in Maryland.
UMBC will expand its work boosting diversity in academia from Maryland to the national level through a new NSF INCLUDES Alliance: Re-Imagining STEM Equity Utilizing Postdoc Pathways (RISE UPP). The RISE UPP Alliance, anticipated to officially launch in fall 2022, is modeled after the AGEP PROMISE Academy, a high-impact initiative co-led by UMBC that supports faculty diversification in the biomedical sciences across University System of Maryland (USM) institutions.
The UMBC-led RISE UPP Alliance will assist the University of Texas System, Texas A&M University System, and University of North Carolina System in creating programs similar to the AGEP PROMISE Academy, but tailored to meet the needs of their specific institutions and systems. The AGEP PROMISE Academy focuses on recruiting diverse Ph.D. recipients and helping them develop their careers from the postdoc to tenure-track faculty stage. UMBC has received a $10 million grant from the National Science Foundation (NSF) to replicate this national model.
Join us for our virtual Open House to explore how UMBC-Shady Grove’s M.P.S. in Biotechnology can help you meet your goals, whether you’re considering a career change, need a respected [….]
Just recently, UMBC appointed biotech industry veteran Mark Schenerman as Graduate Program Director in Biotechnology, marking an important milestone for the program as it looks to move into a new phase of innovation and growth. Schenerman is an active UMBC biotech professor, runs his own biotech consulting business, and built an impressive biotech career that included more than two decades at MedImmune, one of the most important biotech companies in the region’s history.
UMBC’s Biotechnology Master’s program provides specialized training that not only teaches students the latest skills and trends in biotech, but equips them to be successful in sought-after management and leadership roles.
Today, we are excited to announce the winners of our 2nd Annual BioBuzz Awards. The BioBuzz Awards are a celebration of the exciting and groundbreaking work being done by the BioHealth Capital Region (BHCR) life science community and the individuals that make innovation happen across Maryland, Virginia, and Washington, D.C.